CRI Worldwide Appoints Peter H. Glick and Gwen H. Booth to Board of Directors

CLEMENTON, N.J.--(BUSINESS WIRE)--CRI Worldwide, Inc., a leading provider of clinical research services to the global pharmaceutical and biotech industry, has elected Peter H. Glick, General Partner, Ampersand Ventures, and Gwen H. Booth, Senior Vice President, Operations, Accelecare Wound Centers, Inc., to the company’s Board of Directors.

MORE ON THIS TOPIC